Cost effectiveness of antibiotic therapy for otitis media in a military pediatric clinic

Area of Science:

• Pediatric infectious diseases
• Pharmacoeconomics
• Clinical decision analysis

Background:

• Amoxicillin is the standard first-line treatment for acute otitis media (AOM) in children due to perceived safety and low cost.
• However, declining amoxicillin efficacy and adverse effects raise questions about its cost-effectiveness in certain contexts.
• This study evaluates the economic viability of various antibiotic regimens for AOM.

Purpose of the Study:

• To compare the cost-effectiveness of different antibiotic treatments for acute otitis media in a pediatric population.
• To identify the most economically favorable antibiotic choices considering efficacy and adverse event profiles.
• To inform clinical decision-making regarding AOM management in pediatric care settings.

Main Methods:

• A decision analysis model was employed to compare the cost-effectiveness of various antibiotics for AOM.
• The model incorporated data on antibiotic efficacy, adverse effects, and treatment costs.
• Cost-effectiveness was analyzed within a large military pediatric clinic setting.

Main Results:

• Trimethoprim-sulfamethoxazole emerged as the most cost-effective antibiotic regimen for AOM.
• Cefaclor, administered twice daily for 5 days, was identified as the next most cost-effective option.
• The analysis considered both major and minor adverse effects and their impact on overall cost-effectiveness.

Conclusions:

• For acute otitis media in children, trimethoprim-sulfamethoxazole offers superior cost-effectiveness compared to amoxicillin.
• Cefaclor presents a viable and cost-effective alternative regimen.
• Optimizing antibiotic selection for AOM requires balancing efficacy, safety, and economic factors.